Clinical trial
Sirolimus for Autoimmune Disease of Blood Cells
NCT00392951
Study timeline
Study start (unknown)2006-12-01Date precision: month
Registry last updated2019-11-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Autoimmune Pancytopeniaunresolved
Evans Syndromeunresolved
Idiopathic Thrombocytopenic Purpuraunresolved
Anemia, Hemolytic, Autoimmuneunresolved
Autoimmune Neutropeniaunresolved
Lupus Erythematosus, Systemicunresolved
Inflammatory Bowel Diseaseunresolved
Rheumatoid Arthritisunresolved
Interventions
sirolimusDRUG · verified · RxNorm: sirolimus
Sponsors & collaborators
Children's Hospital of Philadelphialead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00392951 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.